Cargando…
Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker
BACKGROUND: Many putative disease blood biomarkers discovered in genomic and proteomic studies await validation in large clinically annotated cohorts of patient samples. ELISA assays require large quantities of precious blood samples and are not high-throughput. The reverse phase protein microarray...
Autores principales: | Aguilar-Mahecha, Adriana, Cantin, Christiane, O'Connor-McCourt, Maureen, Nantel, Andre, Basik, Mark |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672067/ https://www.ncbi.nlm.nih.gov/pubmed/19348683 http://dx.doi.org/10.1186/1477-5956-7-15 |
Ejemplares similares
-
The Effect of Pre-Analytical Variability on the Measurement of MRM-MS-Based Mid- to High-Abundance Plasma Protein Biomarkers and a Panel of Cytokines
por: Aguilar-Mahecha, Adriana, et al.
Publicado: (2012) -
A micro-flow, high-pH, reversed-phase peptide fractionation and collection system for targeted and in-depth proteomics of low-abundance proteins in limiting samples
por: Zurawska, Marta, et al.
Publicado: (2023) -
Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-β and Neu pathway signaling studies: identification of a novel model for TGF-β-induced epithelial-to-mesenchymal transition
por: Lenferink, Anne EG, et al.
Publicado: (2004) -
Mass spectrometry quantification of clusterin in the human brain
por: Chen, Junjun, et al.
Publicado: (2012) -
Glycoproteomic analysis of two mouse mammary cell lines during transforming growth factor (TGF)-β induced epithelial to mesenchymal transition
por: Hill, Jennifer J, et al.
Publicado: (2009)